Mirae Asset Global Investments’s Ionis Pharmaceuticals IONS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $243K | Buy |
6,148
+829
| +16% | +$32.8K | ﹤0.01% | 1028 |
|
|
2025
Q1 | $166K | Buy |
5,319
+57
| +1% | +$1.78K | ﹤0.01% | 1074 |
|
|
2024
Q4 | $189K | Sell |
5,262
-26
| -0.5% | -$934 | ﹤0.01% | 1055 |
|
|
2024
Q3 | $216K | Buy |
5,288
+930
| +21% | +$38K | ﹤0.01% | 1076 |
|
|
2024
Q2 | $206K | Sell |
4,358
-10,723
| -71% | -$506K | ﹤0.01% | 1044 |
|
|
2024
Q1 | $613K | Buy |
+15,081
| New | +$613K | ﹤0.01% | 1812 |
|
|
2023
Q4 | – | Sell |
-12,042
| Closed | -$546K | – | 2572 |
|
|
2023
Q3 | $546K | Buy |
12,042
+129
| +1% | +$5.85K | ﹤0.01% | 1837 |
|
|
2023
Q2 | $489K | Sell |
11,913
-3,658
| -23% | -$150K | ﹤0.01% | 1962 |
|
|
2023
Q1 | $557K | Buy |
+15,571
| New | +$557K | ﹤0.01% | 1868 |
|
|
2021
Q4 | – | Sell |
-6,599
| Closed | -$221K | – | 1659 |
|
|
2021
Q3 | $221K | Buy |
+6,599
| New | +$221K | ﹤0.01% | 1665 |
|
|
2021
Q2 | – | Sell |
-7,772
| Closed | -$350K | – | 1716 |
|
|
2021
Q1 | $350K | Sell |
7,772
-772
| -9% | -$34.8K | ﹤0.01% | 1379 |
|
|
2020
Q4 | $483K | Buy |
8,544
+311
| +4% | +$17.6K | ﹤0.01% | 1325 |
|
|
2020
Q3 | $391K | Buy |
8,233
+3,158
| +62% | +$150K | ﹤0.01% | 1267 |
|
|
2020
Q2 | $299K | Buy |
5,075
+554
| +12% | +$32.6K | ﹤0.01% | 1295 |
|
|
2020
Q1 | $214K | Sell |
4,521
-332
| -7% | -$15.7K | ﹤0.01% | 1295 |
|
|
2019
Q4 | $293K | Buy |
4,853
+248
| +5% | +$15K | ﹤0.01% | 1354 |
|
|
2019
Q3 | $276K | Buy |
4,605
+217
| +5% | +$13K | ﹤0.01% | 1330 |
|
|
2019
Q2 | $282K | Buy |
4,388
+129
| +3% | +$8.29K | ﹤0.01% | 1295 |
|
|
2019
Q1 | $346K | Buy |
+4,259
| New | +$346K | ﹤0.01% | 1156 |
|
|
2016
Q1 | – | Sell |
-4,215
| Closed | -$261K | – | 492 |
|
|
2015
Q4 | $261K | Buy |
+4,215
| New | +$261K | 0.01% | 409 |
|